Biomarkers for Immune Checkpoint Inhibitors in Renal Cell Carcinoma

Immune checkpoint inhibitor (ICI) therapy has revolutionized renal cell carcinoma treatment. Patients previously thought to be palliative now occasionally achieve complete cures from ICI. However, since immunotherapies stimulate the immune system to induce anti-tumor immunity, they often lead to adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Spencer D., Bhuiyan, Ishmam, Soleimani, Maryam, Wang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419620/
https://www.ncbi.nlm.nih.gov/pubmed/37568390
http://dx.doi.org/10.3390/jcm12154987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419620/
https://www.ncbi.nlm.nih.gov/pubmed/37568390
http://dx.doi.org/10.3390/jcm12154987

Ejemplares similares